Format

Send to

Choose Destination
  • Filters activated: Field: Title Word. Clear all
Biomater Sci. 2015 Jul;3(7):923-36. doi: 10.1039/c4bm00427b. Epub 2015 Feb 11.

Lipid-coated polymeric nanoparticles for cancer drug delivery.

Author information

1
Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore. julianachan@ntu.edu.sg.

Abstract

Polymeric nanoparticles and liposomes have been the platform of choice for nanoparticle-based cancer drug delivery applications over the past decade, but extensive research has revealed their limitations as drug delivery carriers. A hybrid class of nanoparticles, aimed at combining the advantages of both polymeric nanoparticles and liposomes, has received attention in recent years. These core/shell type nanoparticles, frequently referred to as lipid-polymer hybrid nanoparticles (LPNs), possess several characteristics that make them highly suitable for drug delivery. This review introduces the formulation methods used to synthesize LPNs and discusses the strategies used to treat cancer, such as by targeting the tumor microenvironment or vasculature. Finally, it discusses the challenges that must be overcome to realize the full potential of LPNs in the clinic.

PMID:
26221931
DOI:
10.1039/c4bm00427b
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Royal Society of Chemistry
Loading ...
Support Center